Cat.#: ACPP-1352
| Despition | Myocilin Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1748 | Human PAFAH1B3 Protein (AC1748) | 5 µg | inquiry |
| ACPP-1761 | Human VCAM1 Protein (AC1761) | 2 µg | inquiry |
| ACPP-1577 | Human WWOX Protein (AC1577) | 2 µg | inquiry |
| ACPP-1498 | Human LIN7A Protein (AC1498) | 2 µg | inquiry |
| ACPP-1425 | Human CAMK4 Protein (AC1425) | 2 µg | inquiry |
| ACPP-1523 | RPE65 Blocking Peptide (AC1523) | 250 µg | inquiry |
| ACPP-1200 | PAX8 Blocking Peptide (AC1200) | 250 µg | inquiry |
| ACPP-1198 | PDE6 Alpha Blocking Peptide (AC1198) | 250 µg | inquiry |
| ACPP-1734 | Human EFNA3 Protein (AC1734) | 5 µg | inquiry |
| ACPP-1112 | Recombinant Human Eph Receptor A2 Protein (6×His Tag) (AC1112) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.